Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Soluble Urokinase Plasminogen Activator Receptor as a Decision Marker for Early Discharge of Patients with COVID-19 Symptoms in the Emergency Department

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Comments on "Outbreak of Mysterious Illness among Hospital Staff: Poisoning of Iatrogenic Reinforced Mass Psychogenic Illness"

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Reply to Jansen et al

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Outbreak of Mysterious Illness Among Hospital Staff: Poisoning or Iatrogenic Reinforced Mass Psychogenic Illness?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Retrospective Evaluation of Two Fast-track Strategies to Rule Out Acute Coronary Syndrome in a Real-life Chest Pain Population

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Resuscitation, prolonged cardiac arrest, and an automated chest compression device

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Investigating the inflammation marker neutrophil-to-lymphocyte ratio in Danish blood donors with restless legs syndrome

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Risk Factors for Being Seronegative following SARS-CoV-2 Infection in a Large Cohort of Health Care Workers in Denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Social Distancing Policies in the Coronavirus Battle: A Comparison of Denmark and Sweden

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Adaptations and modifications to a co-designed intervention and its clinical implementation: a qualitative study in Denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Background: Severe acute respiratory syndrome coronavirus 2 (The Covid-19 pandemic) strains health care capacity. Better risk stratification, with discharge of patients with a predicted mild disease trajectory, can ease this burden. Elevated blood-soluble urokinase plasminogen activator receptor (suPAR) has previously been shown to be associated with risk of intubation in confirmed COVID-19 patients. Objective: To evaluate whether point-of-care measures of suPAR in patients presenting to the emergency department (ED) with symptoms of COVID-19 can identify patients that can be safely discharged. Methods: Observational cohort study including all patients in the ED with symptoms of COVID-19 from March 19 to April 3, 2020. SuPAR was measured at first presentation. Review of electronic patient records 14 days after admission was used to assess disease trajectory. Primary endpoints were mild, moderate, severe, or very severe trajectory. The predictive value of suPAR, National Early Warning Score (NEWS), C-reactive protein (CRP), and duration of symptoms was calculated using receiver operating characteristics (ROC). Results: Of 386 patients, 171 (44%) had a mild disease trajectory, 79 (20%) a moderate, 63 (16%) a severe, and 73 (19%) a very severe disease trajectory. Low suPAR was a strong marker of mild disease trajectory. Results suggest a cut-off for discharge for suPAR < 2.0 ng/mL if suPAR is used as a single parameter, and <3.0 ng/mL when combined with NEWS ≤ 4 and CRP < 10 mg/L. Conclusion: suPAR is a potential biomarker for triage and safe early discharge of patients with COVID-19 symptoms in the ED. suPAR can be used even before SARS-CoV-2 status is known.

OriginalsprogEngelsk
TidsskriftThe Journal of Emergency Medicine (Philadelphia)
Vol/bind61
Udgave nummer3
Sider (fra-til)298-313
Antal sider16
ISSN0736-4679
DOI
StatusUdgivet - sep. 2021

ID: 66131849